Why Invest | Alliance Pharma

Alliance in numbers

A proven track record

20+ Years of operation

30.1 £m Free cash flow (2021)

+23% See through revenue growth (2021)

72% Of revenue from consumer healthcare products (2021)

16 since 2010

INVESTMENT CASE

Investors achieve more with Alliance

With a proven track record Alliance is committed to delivering sustained growth and value for investors.

Our Purpose

To improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.

Our purpose

Our Vision

To be a leading international healthcare business, built around products that are clinically valuable to patients.

We will be both the partner and employer of choice.

Our vision

Our Strategy

There are two main strands to our strategy:

• Delivering solid organic growth from our key brands
• Supplementing this growth with selective, complementary acquisitions in the consumer healthcare space

Underpinned by a focus on:

• Investing in people
• Sustainability

Our strategy

Our Business Model

Leveraging the global platform we’ve created and the capabilities, expertise and relationships that support this enables us to maximise the value of our existing brands and integrate acquired brands with ease.

Our business model

Our Culture

Our culture reflects the spirit of collaboration embedded in our business – the tacit belief that through working together, both internally and with external partners, we can achieve more for our stakeholders and for society as a whole.

Our culture